Methods Forty four participants (12–13 years old; 61% girls) completed the YPAQ following 7 days wearing the Actigraph GT3X+. Mean moderate-to-vigorous physical activity (MVPA) per day was derived ...

Objectives Patients receiving induction chemotherapy for acute myeloid leukaemia (AML) anecdotally describe poor sleep, but sleep disturbances have not been well-characterised in this population. We ...

Third, the objective physical activity measurement (triaxial accelerometers, Actigraph GT3X+) cannot detect whether older adults are swimming, sitting, standing, lying down, or taking an afternoon nap ...

Physical activity was objectively measured using ActiGraph GT3X+ accelerometers, and cognitive function was assessed via the Montreal Cognitive Assessment (MoCA). Multivariable linear regression was ...

We asked the patients to wear two body-worn accelerometer-based devices during their hospital stay; one activPAL (35×53×7 mm, 15 g, activPAL, PAL Technologies, Glasgow, UK) attached to the midpoint of ...

Eli Lilly has expanded a collaboration with data firm Evidation to analyse data from devices and uncover novel digital measures of health.

The relationship between objective sleep tracking, patient-reported sleep and function among liver or kidney transplant recipients using the Actigraph device Print details Share Facebook Twitter ...

Objectives Accelerometers are widely applied in health studies, but lack of standardisation regarding device placement, sampling and data processing hampers comparability between studies. The ...

Background: Difficulty falling asleep (prolonged sleep latency) is a frequently reported problem in school-aged children. Aims: This study aimed to describe the distribution of sleep latency and ...

The ActiGraph GT3X and GT3X+ accelerometer models (ActiGraph, Pensacola, Florida, USA) were utilised and participants were instructed to wear the activity monitor on the right hip during waking hours, ...